Devlin Macgregor announced general availability of three new products on Monday March 8th 2021

* Provasic: The newest generation of blood lipid inhibiting therapeutics, featuring patented Advanced Molecular Delivery System (AMDS), offering near 100% efficacy with absolutely no side effects.

*Narcogesic: Unique, rectally administered two-part epoxy based, pain management system featuring tamper-proof design, that allows for patient self dosing and administration

* Solarestti: The only topical titration proven to block all currently licensed, single and dual-dose mRNA based SARS-Cov-2 (COVID-19) vaccines. For use in adults and children 3 and older only.

https://devlinmacgregor.com